ACCD vs. FIVN, CRTO, UPWK, PLTK, RAMP, ASTH, GDRX, LZ, PINC, and APLD
Should you be buying Accolade stock or one of its competitors? The main competitors of Accolade include Five9 (FIVN), Criteo (CRTO), Upwork (UPWK), Playtika (PLTK), LiveRamp (RAMP), Astrana Health (ASTH), GoodRx (GDRX), LegalZoom.com (LZ), Premier (PINC), and Applied Digital (APLD). These companies are all part of the "business services" industry.
Accolade vs.
Five9 (NASDAQ:FIVN) and Accolade (NASDAQ:ACCD) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.
In the previous week, Five9 had 13 more articles in the media than Accolade. MarketBeat recorded 21 mentions for Five9 and 8 mentions for Accolade. Five9's average media sentiment score of 0.68 beat Accolade's score of 0.31 indicating that Five9 is being referred to more favorably in the media.
Five9 has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, Accolade has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500.
96.6% of Five9 shares are held by institutional investors. Comparatively, 85.0% of Accolade shares are held by institutional investors. 1.8% of Five9 shares are held by company insiders. Comparatively, 8.2% of Accolade shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Five9 currently has a consensus price target of $56.76, suggesting a potential upside of 84.78%. Accolade has a consensus price target of $6.51, suggesting a potential downside of 6.91%. Given Five9's stronger consensus rating and higher probable upside, equities analysts clearly believe Five9 is more favorable than Accolade.
Five9 received 509 more outperform votes than Accolade when rated by MarketBeat users. Likewise, 69.35% of users gave Five9 an outperform vote while only 55.14% of users gave Accolade an outperform vote.
Five9 has higher revenue and earnings than Accolade. Five9 is trading at a lower price-to-earnings ratio than Accolade, indicating that it is currently the more affordable of the two stocks.
Five9 has a net margin of -1.23% compared to Accolade's net margin of -40.36%. Five9's return on equity of 3.62% beat Accolade's return on equity.
Summary
Five9 beats Accolade on 15 of the 18 factors compared between the two stocks.
Get Accolade News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACCD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Accolade Competitors List
Related Companies and Tools
This page (NASDAQ:ACCD) was last updated on 3/25/2025 by MarketBeat.com Staff
